Cited 0 times in Scipus Cited Count

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

Authors
Sa, JK | Hwang, JR | Cho, YJ | Ryu, JY | Choi, JJ | Jeong, SY | Kim, J | Kim, MS | Paik, ES | Lee, YY | Choi, CH | Kim, TJ | Kim, BG | Bae, DS | Lee, Y | Her, NG | Shin, YJ | Cho, HJ | Kim, JY | Seo, YJ | Koo, H | Oh, JW | Lee, T | Kim, HS | Song, SY | Bae, JS | Park, WY | Han, HD | Ahn, HJ | Sood, AK | Rabadan, R | Lee, JK  | Nam, DH | Lee, JW
Citation
Genome biology, 20(1). : 253-253, 2019
Journal Title
Genome biology
ISSN
1474-75961474-760X
Abstract
BACKGROUND: Gynecologic malignancy is one of the leading causes of mortality in female adults worldwide. Comprehensive genomic analysis has revealed a list of molecular aberrations that are essential to tumorigenesis, progression, and metastasis of gynecologic tumors. However, targeting such alterations has frequently led to treatment failures due to underlying genomic complexity and simultaneous activation of various tumor cell survival pathway molecules. A compilation of molecular characterization of tumors with pharmacological drug response is the next step toward clinical application of patient-tailored treatment regimens.
RESULTS: Toward this goal, we establish a library of 139 gynecologic tumors including epithelial ovarian cancers (EOCs), cervical, endometrial tumors, and uterine sarcomas that are genomically and/or pharmacologically annotated and explore dynamic pharmacogenomic associations against 37 molecularly targeted drugs. We discover lineage-specific drug sensitivities based on subcategorization of gynecologic tumors and identify TP53 mutation as a molecular determinant that elicits therapeutic response to poly (ADP-Ribose) polymerase (PARP) inhibitor. We further identify transcriptome expression of inhibitor of DNA biding 2 (ID2) as a potential predictive biomarker for treatment response to olaparib.
CONCLUSIONS: Together, our results demonstrate the potential utility of rapid drug screening combined with genomic profiling for precision treatment of gynecologic cancers.
Keywords

MeSH

DOI
10.1186/s13059-019-1848-3
PMID
31771620
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Biochemistry & Molecular Biology
Ajou Authors
이, 진구
Full Text Link
Files in This Item:
31771620.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse